Sino Biopharmaceutical Limited announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 7,242.995 million compared to CNY 6,221.872 million a year ago. Net income was CNY 1,913.498 million compared to CNY 875.787 million a year ago. Basic earnings per share from continuing operations was CNY 0.1019 compared to CNY 0.0466 a year ago. Diluted earnings per share from continuing operations was CNY 0.0928 compared to CNY 0.0369 a year ago.